Serial Number 90701407
Registration 7388392
700

Registration Progress

Application Filed
May 10, 2021
Under Examination
Apr 12, 2022
Approved for Publication
Feb 15, 2022
Published for Opposition
Feb 15, 2022
Registered
May 14, 2024

Trademark Image

Basic Information

Serial Number
90701407
Registration Number
7388392
Filing Date
May 10, 2021
Registration Date
May 14, 2024
Published for Opposition
February 15, 2022
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
May 14, 2024
Registration
Registered
Classes
005

Rights Holder

AMICUS THERAPEUTICS, INC.

03
Address
3675 Market Street
Philadelphia, PA 19104

Ownership History

AMICUS THERAPEUTICS, INC.

Original Applicant
03
Philadelphia, PA

AMICUS THERAPEUTICS, INC.

Owner at Publication
03
Philadelphia, PA

AMICUS THERAPEUTICS, INC.

Original Registrant
03
Philadelphia, PA

Legal Representation

Attorney
Matthew P. Hintz, Esq.

USPTO Deadlines

Next Deadline
1608 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240514)
Due Date
May 14, 2030
Grace Period Ends
November 14, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

29 events
Date Code Type Description Documents
May 14, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 14, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 6, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 5, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 5, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 15, 2024 IUAF S USE AMENDMENT FILED Loading...
Apr 5, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 15, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 1, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 28, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 28, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 28, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 12, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 10, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 10, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 10, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 23, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 21, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 21, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 21, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 12, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 15, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 15, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 26, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 13, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 13, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 11, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Aug 10, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 13, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of Pompe disease; Pharmaceutical preparations for the treatment of genetic diseases
First Use Anywhere: Oct 12, 2023
First Use in Commerce: Oct 12, 2023

Additional Information

Design Mark
The mark consists of a graphic element which is comprised of two overlapping, irregular-shaped, curving bands and a smaller, leaf-shaped figure positioned above and to the right of the two overlapping bands.

Classification

International Classes
005